Share on LinkedInShare on LinkedIn

ARTICLE · 23 AUGUST 2018

FTC Questions Homeopathic Claims

Frankfurt Kurnit Klein & Selz PC
Frankfurt Kurnit Klein & Selz PC
Contributor
Frankfurt Kurnit Klein & Selz PC

Frankfurt Kurnit Klein & Selz PC

Founded more than 40 years ago as a boutique law firm servicing the entertainment and arts...

View firm profile
Explore more from Frankfurt Kurnit Klein & Selz PC

The Federal Trade Commission announced that it recently closed an investigation into whether marketers made improper claims

United StatesMedia, Telecoms, IT, Entertainment

The Federal Trade Commission announced that it recently closed an investigation into whether marketers made improper claims about the efficacy of the Nerve Pain Away homeopathic topical spray.  The FTC questioned claims by Nature's Pillows, Inc. and Plymouth Direct, Inc. that the product is an effective nerve pain reliever.  

The FTC explained that homeopathy, which dates back to the late 1700s, is based on the theory -- not accepted by most modern medical experts -- that disease symptoms can be treated by minute does of substances that produce similar symptoms when provided in larger doses to healthy people.  The FTC indicated that most homeopathic products are diluted to such an extent that they no longer contain detectable levels of the initial substance.  The FTC said that Nerve Away Pain's purported active ingredients had been diluted 1,000,000,000,000,000,000,000 times. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from